Covestro (OTC:COVTY) vs. Avivagen (OTCMKTS:VIVXF) Financial Comparison

Covestro (OTC:COVTY) and Avivagen (OTCMKTS:VIVXF) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability.

Valuation & Earnings

This table compares Covestro and Avivagen”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Covestro	$15.56 billion	0.84	-$214.29 million	($1.10)	-31.35
Avivagen	$730,000.00	0.00	-$4.71 million	N/A	N/A

Avivagen has lower revenue, but higher earnings than Covestro.

Profitability

This table compares Covestro and Avivagen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Covestro	-1.84%	-3.91%	-1.89%
Avivagen	N/A	N/A	N/A

Volatility & Risk

Covestro has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Avivagen has a beta of -0.27, suggesting that its stock price is 127% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Covestro and Avivagen, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Covestro	0	2	0	0	2.00
Avivagen	0	0	0	0	0.00

Given Avivagen’s higher possible upside, analysts plainly believe Avivagen is more favorable than Covestro.

Summary

Avivagen beats Covestro on 5 of the 8 factors compared between the two stocks.

About Covestro

Covestro AG supplies high-tech polymer materials and application solutions. It operates in two segments, Performance Materials, and Solutions & Specialties. The Performance Materials segment develops, produces, and supplies high-performance materials, such as polyurethanes and polycarbonates, and base chemicals, which include diphenylmethane diisocyanate (MDI), toluylene diisocyanate, long-chain polyols, and polycarbonate resins for use in furniture and wood processing, construction, automotive, and transportation industries, as well as roof structures, insulation for buildings and refrigerators, mattresses, car seats, and other applications. The Solutions & Specialties segment comprises a range of polymer products, including polycarbonates, precursors for coatings and adhesives, MDI specialties and polyols, thermoplastic polyurethanes, specialty films, and elastomers that are used in automotive and transportation, electrical, electronics and household appliances, construction, and healthcare industries, as well as composite resins for solar panel frames, laptops, floodlights, and electric vehicle batteries. The company markets its products through trading houses and distributors. It operates in Europe, the Middle East, Africa, Latin America, the United States, Canada, and the People’s Republic of China. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.